These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9651076)

  • 1. Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis.
    Dolhain RJ; Tak PP; Dijkmans BA; De Kuiper P; Breedveld FC; Miltenburg AM
    Br J Rheumatol; 1998 May; 37(5):502-8. PubMed ID: 9651076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression.
    Smith MD; Slavotinek J; Au V; Weedon H; Parker A; Coleman M; Roberts-Thomson PJ; Ahern MJ
    Rheumatology (Oxford); 2001 Sep; 40(9):965-77. PubMed ID: 11561106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate.
    Kane D; Gogarty M; O'leary J; Silva I; Bermingham N; Bresnihan B; Fitzgerald O
    Arthritis Rheum; 2004 Oct; 50(10):3286-95. PubMed ID: 15476228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of CD68 and MMP-3 expression in synovium by treatment of adalimumab for rheumatoid arthritis.
    Kanbe K; Chiba J; Nakamura A
    Int J Rheum Dis; 2011 Aug; 14(3):261-6. PubMed ID: 21816022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
    Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
    Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological analysis of synovium by treatment of etanercept for rheumatoid arthritis.
    Suzuki Y; Inoue K; Chiba J; Inoue Y; Kanbe K
    Int J Rheum Dis; 2009 Apr; 12(1):7-13. PubMed ID: 20374310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.
    Ducreux J; Durez P; Galant C; Nzeusseu Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR
    Arthritis Rheumatol; 2014 Jan; 66(1):15-23. PubMed ID: 24449571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.
    Hjeltnes G; Hollan I; Førre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
    Clin Exp Rheumatol; 2013; 31(3):415-21. PubMed ID: 23465067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients--a prospective clinical study.
    Sundberg E; Grundtman C; Af Klint E; Lindberg J; Ernestam S; Ulfgren AK; Harris HE; Andersson U
    Arthritis Res Ther; 2008; 10(2):R33. PubMed ID: 18346273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
    Joosten LA; Radstake TR; Lubberts E; van den Bersselaar LA; van Riel PL; van Lent PL; Barrera P; van den Berg WB
    Arthritis Rheum; 2003 Feb; 48(2):339-47. PubMed ID: 12571842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
    Kraan MC; Reece RJ; Barg EC; Smeets TJ; Farnell J; Rosenburg R; Veale DJ; Breedveld FC; Emery P; Tak PP
    Arthritis Rheum; 2000 Aug; 43(8):1820-30. PubMed ID: 10943872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations.
    Morand EF; Leech M; Weedon H; Metz C; Bucala R; Smith MD
    Rheumatology (Oxford); 2002 May; 41(5):558-62. PubMed ID: 12011381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
    Boechat AL; de Oliveira CP; Tarragô AM; da Costa AG; Malheiro A; Guterres SS; Pohlmann AR
    Int J Nanomedicine; 2015; 10():6603-14. PubMed ID: 26543364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate.
    Miranda-Carús ME; Balsa A; Benito-Miguel M; Pérez de Ayala C; Martín-Mola E
    J Immunol; 2004 Jul; 173(2):1463-76. PubMed ID: 15240743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis.
    Kane D; Roth J; Frosch M; Vogl T; Bresnihan B; FitzGerald O
    Arthritis Rheum; 2003 Jun; 48(6):1676-85. PubMed ID: 12794836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
    Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
    Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
    Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
    Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis.
    Kanbe K; Chen Q; Nakamura A; Hobo K
    Clin Rheumatol; 2011 Nov; 30(11):1407-13. PubMed ID: 21909699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.
    Wijbrandts CA; Dijkgraaf MG; Kraan MC; Vinkenoog M; Smeets TJ; Dinant H; Vos K; Lems WF; Wolbink GJ; Sijpkens D; Dijkmans BA; Tak PP
    Ann Rheum Dis; 2008 Aug; 67(8):1139-44. PubMed ID: 18055470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.